China BP Plus and SpiroSonic Regulatory Submissions
Filed with ASX · · 2 pages · English
Story so far
Earlier from Uscom
- Uscom Receives $0.5M R&D Cash Refund
- New BP Plus Patent
- Uscom BPplus Detects New Evidence of Cardiovascular Disease
- Uscom ends 2016 with record manufacturing
- Uscom Awarded Euro Grant for Lung Cancer Diagnostic
Later from Uscom
- New USCOM Evidence for Preeclampsia
- New Uscom Euro Grant for Pulmonary Research
- Uscom Achieves First Cash Flow Positive Quarter
- Uscom Achieves First Cash Flow Positive Quarter Appendix 4C
- Uscom boosts global sales and marketing
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom